Xi Chen Lin
Directeur Technique/Scientifique/R&D chez STRUCTURE THERAPEUTICS INC.
Fortune : - $ au 30/04/2024
Profil
Xi Chen Lin is currently the Chief Scientific Officer at Structure Therapeutics, Inc. and also holds a position as General Manager at Shanghai ShouTi Biotechnology Co. Ltd.
Prior to these roles, Dr. Lin worked as the Head-Asia Pacific External Innovation at Novo Nordisk A from 2016 to 2019.
Dr. Lin received an undergraduate degree from Peking University and a doctorate degree from The Pennsylvania State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Xi Chen Lin
| Sociétés | Poste | Début |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/07/2019 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Directeur Général | - |
Anciens postes connus de Xi Chen Lin
| Sociétés | Poste | Fin |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/07/2019 |
Formation de Xi Chen Lin
| Peking University | Undergraduate Degree |
| The Pennsylvania State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
